26 results
8-K
EX-99.1
SHPH
Shuttle Pharmaceuticals Holdings Inc
22 Mar 24
Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update
9:00am
on developing pretreatment predictive blood tests for prostate cancer patients. These tests will allow for the assessment of risk for cancer treatment
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
22 Mar 24
Prospectus supplement
6:07am
this annual assessment to have a material impact on our financial condition.
Moreover, we cannot predict what healthcare reform initiatives may … Financial Officer with the responsibility of managing the cybersecurity risk assessment and mitigation process.
As part of our overall risk management
8-K
EX-99.1
t1hl37 6p22
14 Nov 23
Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Update
12:00am
424B3
9hg15
24 Aug 23
Prospectus supplement
2:00pm
DRS
nbrcw1f7uh9ltb8 317
29 Sep 22
Draft registration statement
12:00am
424B4
cicth2hs yhlvjz
31 Aug 22
Prospectus supplement with pricing info
6:16am